Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) Invested Capital (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Invested Capital for 9 consecutive years, with $23.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital rose 164.97% to $23.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $23.3 million, a 164.97% increase, with the full-year FY2024 number at $12.6 million, up 136.26% from a year prior.
  • Invested Capital was $23.3 million for Q3 2025 at SANUWAVE Health, up from $12.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $23.3 million in Q3 2025 to a low of -$62.0 million in Q3 2023.
  • A 3-year average of -$18.6 million and a median of -$28.7 million in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: grew 26.06% in 2024, then skyrocketed 174.15% in 2025.
  • SANUWAVE Health's Invested Capital stood at -$34.7 million in 2023, then surged by 136.26% to $12.6 million in 2024, then surged by 84.97% to $23.3 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Invested Capital are $23.3 million (Q3 2025), $12.0 million (Q2 2025), and $8.7 million (Q1 2025).